Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 3, 2017
Patent Application Number
14358572
Date Filed
November 15, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
Various methods and compositions relating to vascular endothelial growth factor receptor 2 (VEGFR2) are provided. In one aspect, a method of increasing expression of the soluble form of VEGFR2 (sVEGFR2) in a subject can include binding an antisense morphoiino to an exon13-intron13 splicing site of VEGFR2 mRNA such that the VEGFR2 niRNA is spliced into a sVEGFR2 isoform.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
